These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2260450

  • 1. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first year of treatment with human growth hormone. Analysis of the Kabi International Growth Study.
    Ranke MB, Guilbaud O.
    Acta Paediatr Scand Suppl; 1990; 370():122-30. PubMed ID: 2260450
    [Abstract] [Full Text] [Related]

  • 2. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [Abstract] [Full Text] [Related]

  • 3. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB, Guilbaud O.
    Acta Paediatr Scand Suppl; 1991 Apr; 379():109-15; discussion 116. PubMed ID: 1815451
    [Abstract] [Full Text] [Related]

  • 4. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study.
    Ranke MB, Lindberg A.
    Acta Paediatr Suppl; 1994 Dec; 406():18-23; discussion 24. PubMed ID: 7734807
    [Abstract] [Full Text] [Related]

  • 6. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.
    Cutfield W, Lindberg A, Albertsson Wikland K, Chatelain P, Ranke MB, Wilton P.
    Acta Paediatr Suppl; 1999 Feb; 88(428):72-5. PubMed ID: 10102057
    [Abstract] [Full Text] [Related]

  • 7. Who is treated with growth hormone today? The Executive Scientific Committee of the Kabi International Growth Study.
    Vanderschueren-Lodeweyckx M.
    Acta Paediatr Scand Suppl; 1990 Feb; 370():107-13; discussion 114. PubMed ID: 2260448
    [Abstract] [Full Text] [Related]

  • 8. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
    Darendeliler F, Berberoğlu M, Ocal G, Adiyaman P, Bundak R, Günöz H, Baş F, Darcan S, Gökşen D, Arslanoğlu I, Yildiz M, Ercan O, Ercan G, Ozerkan E, Can S, Böber E, Adal E, Sarikaya S, Dallar Y, Siklar Z, Bircan I, Bideci A, Yüksel B, Büyükgebiz A.
    J Pediatr Endocrinol Metab; 2005 Oct; 18(10):949-54. PubMed ID: 16355808
    [Abstract] [Full Text] [Related]

  • 9. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM, Bin-Abbas BS, Kaplan SL.
    Horm Res; 1998 Oct; 49 Suppl 2():41-57. PubMed ID: 9730672
    [Abstract] [Full Text] [Related]

  • 10. Catch-up growth after childhood-onset substitution in primary hypothyroidism: is it a guide towards optimal growth hormone treatment in idiopathic growth hormone deficiency?
    Ranke MB, Schwarze CP, Mohnike K, von Mühlendahl KE, Keller E, Willgerodt H, Kiess W.
    Horm Res; 1998 Oct; 50(5):264-70. PubMed ID: 9873194
    [Abstract] [Full Text] [Related]

  • 11. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM, Boersma B, de Muinck Keizer-Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ, Rikken B.
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [Abstract] [Full Text] [Related]

  • 12. Growth response in the first year of growth hormone treatment in prepubertal children with organic growth hormone deficiency: a comparison with idiopathic growth hormone deficiency. The Executive Scientific Committee of the Kabi International Growth Study.
    Price DA, Ranke MB, Guilbaud O.
    Acta Paediatr Scand Suppl; 1990 Apr; 370():131-7; discussion 138. PubMed ID: 2260451
    [Abstract] [Full Text] [Related]

  • 13. Prediction of the growth response of short prepubertal children treated with growth hormone. Swedish Paediatric Study Group for GH treatment.
    Kriström B, Karlberg J, Albertsson-Wikland K.
    Acta Paediatr; 1995 Jan; 84(1):51-7. PubMed ID: 7734899
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of children with idiopathic short stature in the Kabi Pharmacia International Growth Study, and their response to growth hormone treatment. International Board of the Kabi Pharmacia International Growth Study.
    Albertsson-Wikland K.
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():75-8. PubMed ID: 8219481
    [Abstract] [Full Text] [Related]

  • 15. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F, Lindberg A, Wilton P.
    Horm Res Paediatr; 2011 Sep; 76 Suppl 1():42-6. PubMed ID: 21778748
    [Abstract] [Full Text] [Related]

  • 16. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 17. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
    Su Z, Li YH, Ma HM, Chen HS, DU ML, Gu YF.
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
    [Abstract] [Full Text] [Related]

  • 18. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL, Stirling HF, Kelnar CJ, Savage MO, Dunger DB, Buckler JM, Shalet SM.
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [Abstract] [Full Text] [Related]

  • 19. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 May; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 20. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Ranke MB, Guilbaud O, Lindberg A, Cole T.
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():82-8; discussion 89. PubMed ID: 8219483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.